CPMV 最新10-Q变化
将 CPMV 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-14 与上一份 10-Q · 2026-05-20
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +10 | −9 | ~6 | 11 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 1 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 风险因素 | 公司称无重大变化(指向 10-K) | — | — | — | — |
| 其他信息 | 文字有新增/删除 | 0 | 0 | ~1 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-14
Research and development expenses of approximately $16,000 for the three months ended June 30, 2026 and 2025, respectively, are primarily related to salaries and related costs for personnel in research and development functions.
General and administrative expenses of approximately $141,000 for the three months ended June 30, 2026 consist principally of salaries and related costs for personnel and consultants in executive and administrative functions of approximately $117,000, accounting and filing fees of approximately $17,…
Interest expense of approximately $21,000 and $21,000 for the three months ended June 30, 2026 and 2025 , respectively, represents interest expense on convertible notes and loan payables.
Research and development expenses of approximately $31,000 for the six months ended June 30, 2026 are primarily related to salaries and related costs for personnel in research and development functions. The decrease in research and development expenses of approximately $1,000 for the six months ende…
General and administrative expenses of approximately $280,000 for the six months ended June 30, 2026 consist principally of salaries and related costs for personnel and consultants in executive and administrative functions of approximately $218,000, accounting and filing fees of approximately $44,00…
相对上期删除的文字 · 来源:10-Q · 2026-05-20
Research and development expenses of approximately $16,000 for the three months ended March 31, 2026 are primarily related to salaries and related costs for personnel in research and development functions. We believe our research and development expenses will increase significantly over time if we a…
General and administrative expenses of approximately $139,000 for the three months ended March 31, 2026 consist principally of salaries and related costs for personnel and consultants in executive and administrative functions of approximately $101,000, accounting and filing fees of approximately $28…
On July 1, 2024, we entered into a Master Services Agreement with Oncotelic whereby we perform advisory and related services in connection with studies and projects. For the three months ended March 31, 2025, we earned $14,000 for advisory and related services which is recorded in other income in th…
Interest Expense and Accretion to Redemption Value on Convertible Notes
Interest expense of approximately $21,000 and $21,000 for the three months ended March 31, 2026 and 2025, respectively, represents interest expense on convertible notes and loan payables.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议